| Literature DB >> 30166221 |
Véronique Vendrely1, Vincent Launay2, Haythem Najah2, Denis Smith3, Denis Collet4, Caroline Gronnier5.
Abstract
The overall prognosis of patients with esophageal cancer has improved in recent decades due to surgical and medical progress, but overall survival remains poor. Better patient selection and tailored treatment are needed. Different prognostic factors linked with the patient, tumoral characteristics and treatment with curative intent have been identified and are the purpose of this review. Tumor detection at an earlier stage, the advent of new molecules and therapeutic combinations, and the centralization of management in high-volume centers should help to improve the prognosis of esophageal cancer. Improved imaging techniques and a better prediction strategy should guide future treatments.Entities:
Keywords: Chemoradiotherapy; Chemotherapy; Esophageal cancer; Prognosis; Surgery
Mesh:
Year: 2018 PMID: 30166221 DOI: 10.1016/j.dld.2018.08.002
Source DB: PubMed Journal: Dig Liver Dis ISSN: 1590-8658 Impact factor: 4.088